Pharmacology and Toxicology Research

Precision Epidemiology and Overdose

June 1, 2023

MCW scientist Dr. John Mantsch and his partners study overdose patterns to improve prevention strategies.

Science Needs More Physicians

July 20, 2022

MCW creates physician-scientist immersion program to address the shortage of US physicians conducting research.

When Prostate Cancer Returns

June 15, 2022

MCW physician-scientists test new treatment for advanced prostate cancer.

Study Looks at Use of Mitochondria-Targeted Malaria Drug to Prevent Tumor Growth and Dissemination

March 14, 2022

Mitochondria-targeted atovaquone could be an attractive drug to modulate tumor immunity to prevent and treat cancers.

Dr. Kirk Pritchard Receives Grant Renewal to Continue Work to Improve Vascular Function in People with Sickle Cell Disease

April 30, 2021

Kirkwood Pritchard, PhD, has been awarded a four-year, $2.2 million R01 grant renewal for the project titled, “Mechanisms of Inflammation in Sickle Cell Disease” from the National Heart, Lung, and Blood Institute.

MCW Researchers are Inventors on Newly Awarded U.S. Patent for Mito-Honokiol Compounds and Methods to Treat Cancer

December 3, 2020

Medical College of Wisconsin (MCW) researchers led a team that invented the technology in MCW’s recently awarded U.S. Patent 10,836,782 for Mito-Honokiol Compounds and Methods of Synthesis and Use Thereof.

Unlocking the Therapeutic Potential of Medical Cannabis

December 17, 2019

On November 14, the Medical College of Wisconsin School of Pharmacy hosted a professional development seminar focusing on medical cannabis. The seminar provided an overview of the therapeutic potential of medical cannabis.

Dr Qing-song Liu Receives Three RO1 Grants to Continue His Research on Mechanisms of Cocaine Addiction, Anxiety

October 4, 2019

These RO1 grants will support Dr. Liu's ongoing research into aspects of cocaine addiction and the impact of endocannabinoid signaling on stress.

MCW researchers publish collaborative study on potential intervention for lung cancer brain metastasis

July 10, 2019

A collaborative research team from MCW, the University of Michigan, and Aix-Marseille University has a potential new intervention for lung cancer brain metastasis that has little toxicity in a mouse model.